Yogesh Basavaraju

Yogesh Basavaraju is a Researcher at the Department of Experimental & Translational Immunology within DTU Health Technology at the Technical University of Denmark. His research focuses on T-cell biology, cancer immunotherapy, and genome editing technologies, particularly in the context of chronic lymphocytic leukemia and CRISPR-based tools for Chinese hamster ovary cells.

• Key Research Areas: Translational immunology, T-cell reactivity, CRISPR genome editing, neoepitope immunogenicity, cancer immunotherapy, and chronic lymphocytic leukemia

His recent work includes developing MHC-II-based T-cell detection technologies (2024 PhD thesis) and advancing CRISPR applications for gene editing in biotechnology (2023). Collaborations span institutions like DTU Health Technology and international researchers in immunology and biotechnology.

Contact: yogbas@dtu.dk